Marina Kremyanskaya

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Chronic Myeloid Leukemia

Patient Reported

Top Venues

Clinical journal of the American Society of Nephrology : CJASN

Future oncology (London, England)

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

John O Mascarenhas, Anna Rita Migliaccio, Heidi E Kosiorek, Rupali Bhave, Jeanne M Palmer, Andrew T Kuykendall, Ruben A Mesa, Raajit K Rampal, Aaron T Gerds, Abdulraheem Yacoub, Kristen Pettit, Moshe Talpaz, Rami S Komrokji, Marina Kremyanskaya, Agapito Gonzalez, Frank Fabris, Kathryn Johnson, Mikaela Dougherty, Erin M McGovern, Juan Esteban Arango Ossa, Dylan Domenico, Noushin Farnoud, Rona Singer Weinberg, Amy Kong, Vesna Najfeld, Alessandro Maria Maria Vannucchi, Francesca Arciprete, Maria Zingariello, Mario Falchi, Mohamed E Salama, Carolyn Mead-Harvey, Amylou C Dueck, Lilian Varricchio, Ronald Hoffman
A Phase 1b trial of AVID200, a TGFβ 1/3 trap, in patients with myelofibrosis. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Benjamin O Adegbite, Matthew H Abramson, Victoria Gutgarts, Florin M Musteata, Kinsuk Chauhan, Alecia N Muwonge, Kristin A Meliambro, Steven P Salvatore, Sebastian El Ghaity-Beckley, Marina Kremyanskaya, Bridget Marcellino, John O Mascarenhas, Kirk N Campbell, Lili Chan, Steven G Coca, Ellin M Berman, Edgar A Jaimes, Evren U Azeloglu
Patient-Specific Pharmacokinetics and Dasatinib Nephrotoxicity. Clinical journal of the American Society of Nephrology : CJASN (2023)
Benjamin O Adegbite, Matthew H Abramson, Victoria Gutgarts, Florin M Musteata, Kinsuk Chauhan, Alecia N Muwonge, Kristin A Meliambro, Steven P Salvatore, Sebastian El Ghaity-Beckley, Marina Kremyanskaya, Bridget Marcellino, John O Mascarenhas, Kirk N Campbell, Lili Chan, Steven G Coca, Ellin M Berman, Edgar A Jaimes, Evren U Azeloglu
Patient-Specific Pharmacokinetics and Dasatinib Nephrotoxicity. Clinical journal of the American Society of Nephrology : CJASN (2023)
Claire N Harrison, Vikas K Gupta, Aaron T Gerds, Raajit K Rampal, Srdan Verstovsek, Moshe Talpaz, Jean-Jacques Kiladjian, Ruben A Mesa, Andrew T Kuykendall, Alessandro Maria Maria Vannucchi, Francesca Palandri, Sebastian Grosicki, Timothy Devos, Eric Jourdan, Marielle J Wondergem, Haifa Kathrin Al-Ali, Veronika Buxhofer-Ausch, Alberto Álvarez-Larrán, Andrea Patriarca, Marina Kremyanskaya, Adam J Mead, Sanjay Akhani, Yuri Sheikine, Gozde Colak, John O Mascarenhas
Phase III MANIFEST-2: pelabresib + ruxolitinib vs placebo + ruxolitinib in JAK inhibitor treatment-naive myelofibrosis. Future oncology (London, England) 18 (27) (2022)